BioPharm International
CONTINUE TO SITE

OR WAIT null SECS

BioPharm International
Spotlight
COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing
Topic
View MoreAnalytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain
News
All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents
Publications
All PublicationsBioPharm International
Resources
Podcast SeriesBiopharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers
Webcasts
Subscribe
EnewsMagazine

  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences and BioPharm International. All rights reserved.

Spotlight
  • COVID-19 Update
  • Analytics
  • Development
  • Downstream Processing
  • Manufacturing
  • Outsourcing
  • Quality/GMPs
  • Upstream Processing
TopicSee All >
  • Analytical Methods
  • BioBusiness
  • Cell Culture/Fermentation
  • Continuous Processing
  • Drug Delivery
  • Fill/Finish
  • Formulation
  • Process Chromatography
  • Process Control/PAT
  • Process Development
  • QA/QC
  • Separation and Purification
  • Single-Use Systems
  • Supply Chain
  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.

Featured Content

Mr.Ilkin/Stock.Adobe.com

Early Strategizing Tightens Development Timelines

Having a clear clinical strategy early on can shave time off overall development projects.

huenstructurebio.com/Stock.Adobe.com

Bispecific Antibodies are Moving from Research to Clinical Development

With recent approvals of bispecific antibodies, these complex molecules are fast moving out of the research box and into clinical pipelines.

tatyanarow - adobe.stock.com

Considerations for US Fetal Bovine Serum Sourcing

Extensive work has greatly expanded the possibilities for fetal bovine serum sourcing.

markus thoenen/Stock.Adobe.com

Advancing Process Chromatography in DSP

Thanks to technological advances, process chromatography challenges are surmountable, but increasingly complex therapies in the pipeline will demand more efficient processes in the future.

Eugene/Stock.Adobe.com

GMPs for Sterile Manufacturing of Biologics

The complex nature of biologics creates challenges for GMPs in sterile manufacturing, and the EU’s Annex 1 is making an impact.

BillionPhotos.com/Stock.Adobe.com

Coming Together to Enable Cell and Gene Therapy Manufacturing

Precompetitive consortiums seek solutions to industry-wide challenges.

angellodeco - adobe.stock.com

When Is It Appropriate to Outsource Bioanalysis Work to a CRO?

When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.